Safety and Effectiveness of Transvenous Lead Extraction in Patients with Infected Cardiac Resynchronization Therapy Devices; Is It More Risky than Extraction of Other Systems?

导出 OA

翻译打印收藏纠错

作者： Paweł,Stefańczyk ^[1] ; Dorota,Nowosielecka ^[1] ; Anna,Polewczyk ^[2] ; Łukasz,Tułecki ^[3] ; Konrad,Tomków ^[4] ; Wojciech,Jacheć ^[4] ; Ewa,Lewicka ^[5] ; Andrzej,Tomaszewski ^[6] ; Andrzej,Kutarski ^[7]

作者单位： Department of Cardiology, The Pope John Paul II Province Hospital of Zamość Poland, 22-400 Zamość, Poland. ^[1] Department of Physiology, Patophysiology and Clinical Immunology, Collegium Medicum of Jan Kochanowski University, 25-369 Kielce, Poland. ^[2] Department of Cardiac Surgery, Świętokrzyskie Cardiology Center, 25-736 Kielce, Poland. ^[3] Department of Cardiac Surgery, The Pope John Paul II Province Hospital of Zamość Poland, 22-400 Zamość, Poland. ^[4] Department of Cardiology, Faculty of Medical Science in Zabrze, Medical University of Silesia, 40-752 Katowice, Poland. ^[5] Department of Cardiology and Electrocardiotherapy, Medical University of Gdańsk, 80-416 Gdańsk, Poland. ^[6] Department of Cardiology, Medical University of Lublin, 20-059 Lublin, Poland. ^[7]

关键词 cardiac resynchronization therapy infectious indications safety and effectiveness transvenous lead extraction

主题词心脏再同步治疗设备(Cardiac Resynchronization Therapy Devices);共病现象(Comorbidity);除颤器, 植入型(Defibrillators, Implantable);装置取出(Device Removal);人类(Humans);铅(Lead)

DOI 10.3390/ijerph19105803

PMID 35627340

发布时间 2023-03-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交